13F manager/AMPH/

Chuck Royce (Royce & Associates) add Amphastar Pharmaceuticals, Inc.

Chuck Royce (Royce & Associates) add $7.2M of disclosed value in Amphastar Pharmaceuticals, Inc..

Signal
Investor Move
Action
Add
Capital
$7.2M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence